The April 4-7, 2022 Pharmacovigilance Risk Assessment Committee (PRAC) meeting noted no link between COVID vaccines and autoimmune hepatitis (AIH).
The PRAC has concluded that...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and GSK today announced that...
Moderna, Inc. and the nonprofit scientific research organization IAVI, on April 7th, announced a new collaboration to employ mRNA technology to meet the challenge...
Jazz Pharmaceuticals plc and Werewolf Therapeutics, Inc. On Thursday announced that the companies have entered into a licensing agreement under which Jazz has acquired...
Novartis on Wednesday announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and...
Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...